In this article
If you work with peptides at the bench, you already know that the same molecule can behave completely differently depending on how you prepare it. The pH of your diluent, the temperature, even how long you let it sit after mixing, all of these change what happens inside that vial. A new study just showed exactly why, and the answer has nothing to do with contamination or degradation. It's about thermodynamics.
What the Researchers Actually Did
A team using isothermal titration calorimetry (ITC), a method that measures the tiny amounts of heat released or absorbed when molecules interact, decided to study what happens when amino acids and peptides meet carbon dioxide (CO2) in solution. This matters because CO2 is everywhere. It's in the air. It dissolves into your diluent. And when it interacts with the amine groups on amino acids like lysine and arginine, it forms something called a carbamate, a chemical bond between the CO2 and the amino acid. The researchers wanted to understand exactly how this happens, how much heat it releases, and what determines whether the carbamate forms or breaks apart. They tested three things: pure L-lysine, pure L-arginine, and several short peptides containing either lysine or arginine.
The Surprising Finding About Heat
Here's what most researchers would expect: as you add CO2 to a peptide solution, you'd see a steady increase in heat as more carbamates form. Eventually, you'd hit a point where all the available amine sites are "full" and the heat signal would flatten out. That's not what happened. The calorimeter showed a two-phase heat pattern, a first burst of heat, then a second wave that didn't match the carbamate saturation point at all. The second wave came from something else: the collapse of the solution's buffer system as CO2 transformed into carbonate and bicarbonate forms. In plain terms, your solution fights back. The CO2 doesn't just bind to your peptide. It changes the entire chemical environment, shifting pH, converting between different carbon-containing species, and all of those changes release or absorb heat too. The researchers called this the "coupled carbonate-amine equilibrium network."
Why Lysine Outperforms Arginine
The study found that lysine forms carbamates much more readily than arginine. Lysine has two different amine sites, one at the "tail" end (called the epsilon amine) and one at the "head" (the alpha amine). Both can grab CO2, sometimes both at once, creating what's called a dicarbamate. The epsilon-carbamate on lysine turned out to be one of the most stable carbamate-forming sites ever measured in aqueous amine systems. Arginine, despite having a similar structure, didn't form carbamates as easily. This matters for anyone designing peptide-based systems because it tells you: not all amine groups are equal. The local chemical environment, nearby atoms, charge distribution, how the peptide folds, matters more than just having an amine present.What This Means For Your Bench Work
Here's the practical takeaway: when you reconstitute a peptide, you're not just dissolving a solid into water. You're starting a thermodynamic conversation between your peptide, your diluent, and whatever CO2 is already dissolved in there. If you're using bacteriostatic water, the pH matters. If you're working at room temperature versus 4°C, the equilibrium shifts. If you're preparing stock solutions and freezing them, the freeze-thaw cycle can change the local chemical environment enough to alter how your peptide behaves next time you thaw it. The researchers showed that maximizing CO2 retention, maximizing amine-mediated capture, and maximizing carbamate formation are three different optimization problems. You can't optimize all three at once. Changing pH helps one goal but hurts another. Changing temperature does the same. That means your reconstitution protocol isn't just about following instructions. It's about choosing which thermodynamic outcome you actually want for your particular experiment. The full paper is available on bioRxiv under the title "The Thermodynamics of Biomolecular CO2 Capture: Disentangling Equilibria in Amino-Acid-based Systems."Frequently asked questions
Why does my peptide seem to behave differently even when I follow the same reconstitution protocol?
CO2 dissolved in your diluent interacts with peptide amine groups in ways that shift with pH and temperature, changing the chemical equilibrium.
Does the type of amino acid in my peptide affect how it interacts with CO2?
Yes. Lysine forms stable carbamates much more readily than arginine due to its epsilon amine group.
Should I use CO2-free water for reconstitution?
Consider your goal: CO2-free diluent prevents uncontrolled carbamate formation but also removes a natural buffer component that may matter for your specific experiment.
Prompted by this coverage at bioRxiv →
Related from our lab: the pen · cartridges · bacteriostatic water · reconstitution calculators
Shared by PreppinPeppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.
What the research community gets wrong about CO2 and peptide carbamate formation in solution
- Thinking the heat signal is one smooth curve. Many at the bench expect that adding CO2 to a peptide solution gives one steady rise in heat until every amine site is full. Calorimetry studies of amino acid systems show a two-phase pattern instead, because the carbonate and bicarbonate buffer also shifts and releases or absorbs heat of its own.
- Treating every amine group as the same. An amine is not just an amine. On lysine, the side-chain (epsilon) amine grabs CO2 much more readily than arginine's guanidinium group does. The atoms nearby, the charge, and how the peptide folds change how easily a carbamate forms.
- Assuming CO2-free water is always the better choice. Removing dissolved CO2 does cut down uncontrolled carbamate formation, but it also removes a natural buffer component. Whether that helps or hurts depends on what your particular experiment needs, not on a single rule.
- Believing that following the same protocol gives the same solution. The pH of your diluent and the temperature you work at both move the equilibrium. Two vials prepared the same way at 4 degrees C and at room temperature can sit at different points in that equilibrium.
- Picturing reconstitution as just dissolving a solid in water. Mixing a peptide with diluent starts a set of coupled reactions between the peptide, the water, and any dissolved CO2. You cannot maximize CO2 retention, amine capture, and carbamate stability all at once, so it helps to decide which one your study actually cares about.
From our bench: If you reconstitute the same peptide in more than one batch, measure the pH of each final solution with a calibrated meter and log it next to the diluent you used, the temperature you worked at, and whether the water was freshly opened or had been sitting. Record what you actually read, with no rounding to a number you expected. If you notice a batch that reads differently from the others, tell us what changed in your setup so we can compare notes across benches.
Sources
- Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
- Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
- Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
- PubChem , L-Lysine (CID 5962), showing the alpha and epsilon amino groups
- PubChem , L-Arginine (CID 6322), showing the guanidinium and amine groups
- PubChem , Carbamic acid (CID 277), the carbamate product formed when CO2 reacts with an amine
✔ Reviewed by Bryan Le, PharmD, RPh
Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.
